Skip to main content


Firm Analyst
Canaccord Genuity
John Newman, PhD
Chardan Capital Markets
Gbola Amusa, MD, CFA
Chris Shibutani, MD
Goldman Sachs
Terence Flynn, PhD
Chris Howerton, PhD
Mark Breidenbach, PhD

Seres Therapeutics, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Seres Therapeutics, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Seres Therapeutics, Inc. or its management. Seres Therapeutics, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Back to top